Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

72 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Resection of hepatocellular cancer ≤2 cm: results from two Western centers.
Roayaie S, Obeidat K, Sposito C, Mariani L, Bhoori S, Pellegrinelli A, Labow D, Llovet JM, Schwartz M, Mazzaferro V. Roayaie S, et al. Among authors: pellegrinelli a. Hepatology. 2013 Apr;57(4):1426-35. doi: 10.1002/hep.25832. Epub 2013 Jan 25. Hepatology. 2013. PMID: 22576353 Free PMC article.
Transarterial chemoembolization for hepatocellular carcinoma with a new generation of beads: clinical-radiological outcomes and safety profile.
Spreafico C, Cascella T, Facciorusso A, Sposito C, Rodolfo L, Morosi C, Civelli EM, Vaiani M, Bhoori S, Pellegrinelli A, Marchianò A, Mazzaferro V. Spreafico C, et al. Among authors: pellegrinelli a. Cardiovasc Intervent Radiol. 2015 Feb;38(1):129-34. doi: 10.1007/s00270-014-0907-0. Epub 2014 May 29. Cardiovasc Intervent Radiol. 2015. PMID: 24870698
Osteopontin, E-cadherin, and β-catenin expression as prognostic biomarkers in patients with radically resected gastric cancer.
Di Bartolomeo M, Pietrantonio F, Pellegrinelli A, Martinetti A, Mariani L, Daidone MG, Bajetta E, Pelosi G, de Braud F, Floriani I, Miceli R. Di Bartolomeo M, et al. Among authors: pellegrinelli a. Gastric Cancer. 2016 Apr;19(2):412-420. doi: 10.1007/s10120-015-0495-y. Epub 2015 Apr 11. Gastric Cancer. 2016. PMID: 25862567 Clinical Trial.
Preoperative Capecitabine, Oxaliplatin, and Irinotecan in Resectable Gastric or Gastroesophageal Junction Cancer: Pathological Response as Primary Endpoint and FDG-PET Predictions.
Berenato R, Morano F, Pietrantonio F, Cotsoglou C, Caporale M, Infante G, Pellegrinelli A, Alessi A, Battiston C, Coppa J, Padovano B, Mennitto A, Niger M, Fucà G, Lazzati S, Greco G, Delconte G, de Braud F, Mazzaferro V, Di Bartolomeo M. Berenato R, et al. Among authors: pellegrinelli a. Oncology. 2017;93(5):279-286. doi: 10.1159/000479154. Epub 2017 Sep 8. Oncology. 2017. PMID: 28881354 Clinical Trial.
A review on biomarkers for prediction of treatment outcome in gastric cancer.
Pietrantonio F, De Braud F, Da Prat V, Perrone F, Pierotti MA, Gariboldi M, Fanetti G, Biondani P, Pellegrinelli A, Bossi I, Di Bartolomeo M. Pietrantonio F, et al. Among authors: pellegrinelli a. Anticancer Res. 2013 Apr;33(4):1257-66. Anticancer Res. 2013. PMID: 23564763 Free article. Review.
Bax expression is predictive of favorable clinical outcome in chemonaive advanced gastric cancer patients treated with capecitabine, oxaliplatin, and irinotecan regimen.
Pietrantonio F, Biondani P, de Braud F, Pellegrinelli A, Bianchini G, Perrone F, Formisano B, Di Bartolomeo M. Pietrantonio F, et al. Among authors: pellegrinelli a. Transl Oncol. 2012 Jun;5(3):155-9. doi: 10.1596/tlo.12151. Epub 2012 Jun 1. Transl Oncol. 2012. PMID: 22741034 Free PMC article.
Role of BAX for outcome prediction in gastrointestinal malignancies.
Pietrantonio F, Biondani P, Ciurlia E, Fanetti G, Tessari A, Bertarelli G, Bossi I, Musella V, Melotti F, Di Bartolomeo M, Valvo F, Pellegrinelli A, Milione M, Perrone F, de Braud F. Pietrantonio F, et al. Among authors: pellegrinelli a. Med Oncol. 2013;30(3):610. doi: 10.1007/s12032-013-0610-z. Epub 2013 May 23. Med Oncol. 2013. PMID: 23700226 Review.
72 results